In-Depth Insights into the Liquid Biopsy For Cancer Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Are the Projected Expansion Rates of the Liquid Biopsy For Cancer Diagnostics Market for the Next Decade?
The liquid biopsy for cancer diagnostics market has witnessed substantial growth. It is forecasted to expand from $9.23 billion in 2024 to $10.78 billion in 2025, at a CAGR of 16.8%. This growth has been supported by advancements in genomic research, increasing awareness of liquid biopsy advantages, a rising incidence of cancer, growing demand for non-invasive cancer testing, and the expansion of precision medicine initiatives.
The liquid biopsy for cancer diagnostics market is projected to expand significantly, reaching $19.32 billion by 2029 at a CAGR of 15.7%. Growth in this sector is driven by increased adoption in routine cancer diagnostics, early detection initiatives, expansion of cancer screening programs, a stronger emphasis on personalized oncology, and rising research investments in liquid biopsy technologies. Key trends include the emergence of multi-omics liquid biopsy approaches, AI-powered biopsy analysis, expansion of applications beyond oncology, the development of blood-based cancer biomarkers, and tailored liquid biopsy assays for specific cancer types.
What Combination of Drivers Is Leading to Accelerated Growth in the liquid biopsy for cancer diagnostics Market?
The rising incidence of cancer is expected to drive the growth of the liquid biopsy for cancer diagnostics market. Cancer refers to a range of diseases characterized by abnormal cell growth. Liquid biopsies help detect early cancer or tumor recurrence, monitor therapy, and assess risks. The National Cancer Institute reported that there were 18.1 million cancer survivors in the U.S. in 2024, a figure expected to rise to 22.5 million by 2032. By 2040, the number of new cancer cases annually is projected to reach 29.9 million. Thus, the increasing incidence of cancer is contributing to the growth of the liquid biopsy market for cancer diagnostics.
Explore Comprehensive Insights Into The Global Liquid Biopsy For Cancer Diagnostics Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12205&type=smp
Which Companies Are Redefining the Future of the Liquid Biopsy For Cancer Diagnostics Market?
Major companies operating in the liquid biopsy for cancer diagnostics market include:
• F. Hoffman La Roche Ltd._x000D_
• Thermo Fisher Scientific Inc._x000D_
• Agilent Technologies Inc._x000D_
• Illumina Inc._x000D_
• The Menarini Group_x000D_
What Trends Are Poised to Drive the Future Success of the Liquid Biopsy For Cancer Diagnostics Market?
Product innovations are becoming a significant trend in the liquid biopsy for cancer diagnostics market. Leading companies are focusing on developing innovative products to strengthen their market presence. For example, in June 2023, BostonGene, a US-based biomedical software company, launched new liquid biopsy solutions to identify clinically relevant gene alterations. This expanded test portfolio will accelerate the creation of new assays, analytical tools, and pipelines, enabling precision medicine. The solution combines AI-driven molecular and immunological profiling to analyze tumors, microenvironments, and host immunity, supporting immunotherapy treatment and offering insights into immune-related disorders while monitoring disease progression and treatment response.
Secure Your Global Liquid Biopsy For Cancer Diagnostics Market Report Now for Fast and Efficient Delivery!
Which Segments Play a Crucial Role in the Expansion of the Liquid Biopsy For Cancer Diagnostics Market?
The liquid biopsy for cancer diagnostics market covered in this report is segmented –
1) By Type: Product, Services
2) By Sample: Blood, Urine, Saliva
3) By Cancer: Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers
4) By End-User: Hospitals, Diagnostic Centers, Other End-Users
Subsegments:
1) By Product: Circulating Tumor Cells (CTCs) Detection Kits, Circulating Tumor DNA (ctDNA) Detection Kits, Exosome Isolation Kits, Sample Collection Devices
2) By Services: Testing Services, Analytical Services, Bioinformatics Services
What Are the Leading Regions in the Liquid Biopsy For Cancer Diagnostics Market Expansion?
North America was the largest region in the liquid biopsy for cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liquid biopsy for cancer diagnostics market report during the forecast period. The regions covered in the liquid biopsy for cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Liquid Biopsy For Cancer Diagnostics Market Classified and Defined in Market Analysis?
Liquid biopsy for cancer diagnostics is a less invasive method than traditional tissue biopsies, which include evaluating genetic material or biomarkers discovered in a patient’s blood or other bodily fluids to find and monitor the presence of cancer. It is commonly used for screening and identifying non-small cell lung cancer (NSCLC) and as a gastrointestinal and ovarian liquid biopsy for cancer diagnostics.
Browse Through More Similar Reports By The Business Research Company:
Bioabsorbable Stents Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Cardiovascular Medical Lasers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
Blood Collection Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
